This article was originally published in The Rose Sheet
"Quiet innovations," or product launches that are not highly publicized, are key to building Colgate's long-term business, CEO Reuben Mark says during recent presentation at the Morgan Stanley Global Consumer Conference in New York City. Exec cites Colgate launches such as Simply White and Max Fresh toothpastes, as well as the upcoming 360° toothbrush with tongue cleaner as examples of "quiet innovations" which will continue to generate sales. Mark also reassured analysts that Colgate's global business remains strong despite the firm's recent decision to lower its earnings targets for the third and fourth quarters (1"The Rose Sheet" Sept. 27, 2004, p. 8). Colgate will continue to focus on core categories and growing market share and expects earnings per share to be $.06-$.10 next year, he adds...
You may also be interested in...
Colgate's effort to boost marketing support to maintain leading share positions is fueling volume sales and market share growth, but also will result in lower than expected earnings in the second half of the year, Chairman and CEO Reuben Mark warned investors during a conference call Sept. 20
The former CEO of Cipla’s India business is set to steer JB Chemicals and Pharmaceuticals, as the Indian firm embarks on a new phase of growth, backed by a revamped board, following its takeover by US private equity firm KKR.
Moderna led by releasing the trial protocol for its COVID-19 vaccine study, followed by Pfizer, as industry faces demands for transparency.